compare glp 1 Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Indications for GLP-1/GIP RA Summary
Description
The SURMOUNT 4 is a trial to assess the effects of tirzepatide, a dual receptor agonist targeting GLP-1 and GIP, on long-term weight reduction over 2 years in those without diabetes
Ongoing or severe pain should not be managed at home, as gallbladder complications may require investigation or treatment
[DOI] [PubMed] [Google Scholar] [145].Rosenstock J, Guerci B, Hanefeld M, Gentile S, Aronson R, Tinahones FJ, Roy-Duval C, Souhami E, Wardecki M, Ye J, Perfetti R, Heller S, I
Her home medications included semaglutide, metformin, lisinopril, hydrochlorothiazide, sucralfate, omeprazole, and docusate as needed
Yes, as long as the cooler is pre-cooled
